AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Dranitsaris, G Leung, P Mather, J Oza, A
Citation: G. Dranitsaris et al., Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate, ANTI-CANC D, 11(7), 2000, pp. 591-601

Authors: Hoskins, P Eisenhauer, E Vergote, I Dubuc-Lissoir, J Fisher, B Grimshaw, R Oza, A Plante, M Stuart, G Vermorken, J
Citation: P. Hoskins et al., Phase II feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: A National Cancer Institute of Canada Clinical Trials Group Study, J CL ONCOL, 18(24), 2000, pp. 4038-4044

Authors: Goss, PE Strasser, K Marques, R Clemons, M Oza, A Goel, R Blackstein, M Kaizer, L Sterns, EE Nabholtz, JM De Coster, R Crump, M Abdolell, M Qi, S
Citation: Pe. Goss et al., Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer, BREAST CANC, 64(2), 2000, pp. 177-188

Authors: Goss, PE Oza, A Goel, R Nabholtz, JM De Coster, R Bruynseels, J Reid, C Wadden, N Crump, M Tye, LM
Citation: Pe. Goss et al., Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer, BREAST CANC, 59(1), 2000, pp. 55-68

Authors: Wong, R Milosevic, M Sturgeon, J Pintilie, M Fyles, A Levin, W Rosen, B Depetrillo, D Oza, A Manchul, L Murphy, J Chapman, W
Citation: R. Wong et al., Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: Results of a prospective treatment protocol, INT J RAD O, 45(3), 1999, pp. 657-665

Authors: Ross, G Malfetano, J Clarke-Pearson, D Oza, A Gore, M Beckman, R Fields, S Lane, S Dane, G
Citation: G. Ross et al., IV topotecan (TOPT) in patients (Pts) who relapse following platinum(P)/paclitaxel(TX) treatment: subset analysis of a phase III trial, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 285-289
Risultati: 1-6 |